Cheryl Silberman

What is a clinically meaningful change on the Functional Assessment of Cancer Therapy–Lung (FACT-L) Questionnaire?Results from Eastern Cooperative Oncology Group (ECOG) Study 5592

David Cella, David T. Eton, Diane L. Fairclough et al. · Journal of Clinical Epidemiology · 2002 · 376 citations

Functional Assessment, Meaningful Change, Oncology +8

The Prevalence of COPD

Paul Stang, Eva Lydick, Cheryl Silberman et al. · CHEST Journal · 2000 · 200 citations

Epidemiology, Pulmonary Care, Occupational Lung Diseases +6

Weight Loss, Glycemic Control, and Changes in Cardiovascular Biomarkers in Patients With Type 2 Diabetes Receiving Incretin Therapies or Insulin in a Large Cohort Database

Edward S. Horton, Cheryl Silberman, Keith L. Davis et al. · Diabetes Care · 2010 · 152 citations · Full text

Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes

John R. Erbey, Cheryl Silberman, Eva Lydick · The American Journal of Medicine · 2000 · 99 citations

Obesity, Metabolic Syndrome, Metabolic Disorder +7

Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI)

Kathleen J. Yost, Susan Yount, David T. Eton et al. · Breast Cancer Research and Treatment · 2005 · 28 citations

Functional Assessment, Breast Oncology, Cancer Screening +9